Sort by
Refine Your Search
-
Country
-
Employer
- University of North Carolina at Chapel Hill
- University of Minnesota
- Rutgers University
- Stanford University
- UNIVERSITY OF HELSINKI
- University of Florida
- University of Washington
- Baylor College of Medicine
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Icahn School of Medicine, CABCT
- Indiana University
- Institut de l'Audition/Institut Pasteur
- Josep Carreras Leukaemia Research Institute (IJC)
- KU LEUVEN
- McGill University
- Nencki Institute of Experimental Biology
- Northeastern University
- RCSI - Royal College of Surgeons in Ireland
- Research Center for Molecular Medicine (CeMM), ÖAW
- The Ohio State University
- The University of Arizona
- Umeå universitet stipendiemodul
- University Hospital Magdeburg
- University of Kansas Medical Center
- University of Maryland, Baltimore
- University of Nebraska Medical Center
- University of Pittsburgh, Pittsburgh , Pennsylvania, US
- University of Texas at Tyler
- 18 more »
- « less
-
Field
-
Center for Advancement of Blood Cancer Therapies (CABCT) (https://icahn.mssm.edu/research/cabct ). The successful candidate will work on projects involving human induced pluripotent stem cells (iPSCs) and
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
motivated candidates with a strong record of scientific productivity and innovation. Ideal applicants will have expertise in virology, molecular biology, gene delivery, immune cell therapy, computational
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
to study the molecular mechanisms of post-transcriptional gene expression in health and disease. We are an enthusiastic, collaborative team dedicated to tackling outstanding questions at the interface of RNA
-
tolerance and treat disease at reduced doses, understanding the mechanisms driving immune tolerance following AAV liver-directed gene therapy, and evaluating the immune responses associated with AAV
-
understand the pathogenesis of inflammatory bowel disease (IBD) and developing gene editing therapies for IBD. The role will include working with IBD patient-derived organoids, advancing human in vitro assays
-
specializes in precision cardiovascular medicine, leveraging cutting-edge approaches such as human iPSC-derived 2D cardiovascular cells, 3D vascularized cardioids, CRISPR gene editing, high-throughput CRISPRko
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
of which decrease quality and quantity of life. Ironically, recent success in cancer therapies has increased the incidence of clotting complications in patients with cancer. At the same time, we are becoming
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
looking for a motivated Postdoctoral Research Associates to join our basic and translational research team in the UNC Gene Therapy Center My research is focuses on two general areas: 1) Molecular principles
-
determining astrocyte neurotoxic and neuroprotective phenotype. Basic research concepts studied in the laboratory are being applied to the development of novel gene therapy vectors for the treatment of retinal
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
. Chengwen Li in the Gene Therapy Center at the University of North Carolina at Chapel Hill. The general research interest is to develop adeno-associated virus (AAV) vectors to treat various diseases such as